These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2837100)

  • 21. Synovial sarcoma: an immunohistochemical and ultrastructural study.
    Ordóñez NG; Mahfouz SM; Mackay B
    Hum Pathol; 1990 Jul; 21(7):733-49. PubMed ID: 2163364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential histogenic relationship of the peripheral nerve to synovioma.
    Ichinose H; Powell L; Hoerner HE; Derbes VJ; Byers JF
    Cancer Res; 1979 Oct; 39(10):4270-3. PubMed ID: 225019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein gene product 9.5 (PGP 9.5) is not a specific marker of neural and nerve sheath tumors: an immunohistochemical study of 95 mesenchymal neoplasms.
    Campbell LK; Thomas JR; Lamps LW; Smoller BR; Folpe AL
    Mod Pathol; 2003 Oct; 16(10):963-9. PubMed ID: 14559978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant peripheral nerve sheath tumors of the skin.
    George E; Swanson PE; Wick MR
    Am J Dermatopathol; 1989 Jun; 11(3):213-21. PubMed ID: 2729526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neurofibroma with mucus-producing glands. Report of a case and literature review].
    Cuesta T; Estupiñán B; Salazar S; Carballosa E
    Rev Neurol; 1999 Feb 1-15; 28(3):245-7. PubMed ID: 10714288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation.
    Allander SV; Illei PB; Chen Y; Antonescu CR; Bittner M; Ladanyi M; Meltzer PS
    Am J Pathol; 2002 Nov; 161(5):1587-95. PubMed ID: 12414507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microscopic intraneural perineurial cell proliferations in patients with neurofibromatosis type 1.
    Agaimy A
    Ann Diagn Pathol; 2014 Apr; 18(2):95-8. PubMed ID: 24461704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study.
    O'Sullivan MJ; Kyriakos M; Zhu X; Wick MR; Swanson PE; Dehner LP; Humphrey PA; Pfeifer JD
    Mod Pathol; 2000 Nov; 13(11):1253-63. PubMed ID: 11106084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucinous, gland predominant synovial sarcoma of a large peripheral nerve: a rare case closely mimicking metastatic mucinous carcinoma.
    Weinreb I; Perez-Ordoñez B; Guha A; Kiehl TR
    J Clin Pathol; 2008 May; 61(5):672-6. PubMed ID: 18441160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myxoid synovial sarcoma: an underappreciated morphologic subset.
    Krane JF; Bertoni F; Fletcher CD
    Mod Pathol; 1999 May; 12(5):456-62. PubMed ID: 10349982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The diagnostic utility of reduced immunohistochemical expression of SMARCB1 in synovial sarcomas: a validation study.
    Ito J; Asano N; Kawai A; Yoshida A
    Hum Pathol; 2016 Jan; 47(1):32-7. PubMed ID: 26520417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth-associated protein 43 in differentiating peripheral nerve sheath tumors from other non-neural spindle cell neoplasms.
    Chen WS; Chen PL; Lu D; Lind AC; Dehner LP
    Mod Pathol; 2014 Feb; 27(2):184-93. PubMed ID: 23887302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant peripheral nerve sheath tumors with divergent differentiation.
    Ducatman BS; Scheithauer BW
    Cancer; 1984 Sep; 54(6):1049-57. PubMed ID: 6432304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A series of 397 peripheral neural sheath tumors: 30-year experience at Louisiana State University Health Sciences Center.
    Kim DH; Murovic JA; Tiel RL; Moes G; Kline DG
    J Neurosurg; 2005 Feb; 102(2):246-55. PubMed ID: 15739552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predominantly epithelial-type synovial sarcoma with overwhelming neuroendocrine differentiation: a potential diagnostic pitfall.
    Chen Y; Zhou N; Guo D; Wang X; He X; Xu Y
    Diagn Pathol; 2022 Jul; 17(1):59. PubMed ID: 35820955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics.
    Foo WC; Cruise MW; Wick MR; Hornick JL
    Am J Clin Pathol; 2011 Jun; 135(6):839-44. PubMed ID: 21571956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of bcl-2 protein in synovial sarcoma: a comparative study of other soft tissue spindle cell sarcomas and an additional analysis by fluorescence in situ hybridization.
    Hirakawa N; Naka T; Yamamoto I; Fukuda T; Tsuneyoshi M
    Hum Pathol; 1996 Oct; 27(10):1060-5. PubMed ID: 8892591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions.
    Weiss SW; Nickoloff BJ
    Am J Surg Pathol; 1993 Oct; 17(10):1039-45. PubMed ID: 7690524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoplasms with neural differentiation: a review. Part II: Malignant neoplasms.
    Sangüeza OP; Requena L
    Am J Dermatopathol; 1998 Feb; 20(1):89-102. PubMed ID: 9504678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synovial sarcoma: an immunohistochemical study.
    Salisbury JR; Isaacson PG
    J Pathol; 1985 Sep; 147(1):49-57. PubMed ID: 2995626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.